Back to trial detailsIntake questionnaire
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Applying to Providence Saint Mary Regional Cancer Center · Walla Walla, Washington
Answer a few short questions to share with the research team.
0 of 3 answered